Results 111 to 120 of about 374,365 (198)

Vagino-Laparoscopic Conservative Strategy of Hysterectomy in Indicated Cases of Severe Pelvic Endometriosis Followed by 24 Months of Depot-Medroxyprogesterone Acetate Therapy- A Symptom-Solving Treatment Model to Ease Surgical Challenges. [PDF]

Int J Womens Health, 2023
Purohit R, Sharma JG, Meher D, Samy MM.
europepmc   +1 more source

Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosis. [PDF]

Pharmacogenet Genomics, 2022
Haas DW, Mngqibisa R, Francis J, McIlleron H, Robinson JA, Kendall MA, Baker P, Mawlana S, Badal-Faesen S, Angira F, Omoz-Oarhe A, Samaneka WP, Denti P, Cohn SE, AIDS Clinical Trials Group A5338 Study Team.   +14 more
europepmc   +1 more source

A Systematic Review and Meta-Analysis of the Association Between Depot Medroxyprogesterone Acetate and Cerebral Meningioma. [PDF]

Cancers (Basel)
Reynolds LM, Arend RC, Griffin RL.
europepmc   +1 more source

Clinical and pathological study of feline mammary fibroadenomatous change associated with depot medroxyprogesterone acetate therapy [PDF]

Arquivo Brasileiro de Medicina Veterinária e Zootecnia, 2004
A.P. Loretti, M.R.S. Ilha, I. Breitsameter, C.S. Faraco   +3 more
doaj   +1 more source

Return to fertility after subcutaneous depot medroxyprogesterone acetate: a narrative review. [PDF]

BMJ Sex Reprod Health
Osoti A, Kidula N, Mengesa LB, Kiarie JN.   +3 more
europepmc   +1 more source

A Semimechanistic Pharmacokinetic Model for Depot Medroxyprogesterone Acetate and Drug-Drug Interactions With Antiretroviral and Antituberculosis Treatment. [PDF]

Clin Pharmacol Ther, 2021
Francis J, Mngqibisa R, McIlleron H, Kendall MA, Wu X, Dooley KE, Firnhaber C, Godfrey C, Cohn SE, Denti P, A5093, A5283, A5338 study teams.   +12 more
europepmc   +1 more source

Understanding clients' and providers' perspectives on the implementation of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) for self-injection programming in Nigeria. [PDF]

BMJ Glob Health
Challa S, Griffith M, Jegede A, Tijani A, Himes E, Idiodi I, Okoli C, Dimowo S, Omoluabi E, Liu JX.   +9 more
europepmc   +1 more source

The potential for intramuscular depot medroxyprogesterone acetate as a self-bridging emergency contraceptive. [PDF]

Contracept X, 2021
Schickler R, Crabtree-Sokol D, Patel J, Bender N, Nelson AL, Nguyen BT.   +5 more
europepmc   +1 more source

Influence of Movement Restriction During the COVID-19 Pandemic on Uptake of DMPA-SC and Other Injectable Contraceptive Methods in Nigeria

Open Access Journal of Contraception
Adewole Adebola Adefalu,1 Olufunke Abimbola Bankole,2 Funmilayo Olabode,2 Mojuba Bimbo Afolabi,2 Miranda Atare Buba,2 Victor Dafe,2 Mishael Nnanna Kalu,2 Emily Watkins3 1JSI Research & Training Institute, Inc., Atlanta, GA, USA; 2JSI Research & ...
Adefalu AA, Bankole OA, Olabode F, Afolabi MB, Buba MA, Dafe V, Kalu MN, Watkins E   +7 more
doaj  

Interaction of Depot Medroxyprogesterone Acetate and Tenofovir Disoproxil Fumarate/Emtricitabine on Peripheral Blood Mononuclear Cells and Cervical Tissue Susceptibility to HIV Infection and Pharmacokinetics. [PDF]

J Acquir Immune Defic Syndr, 2023
Coleman JS, Diniz CP, Fuchs EJ, Marzinke MA, Aung W, Bakshi RP, Farzadegan H, Bream JH, Nilles TL, Hudson S, Bumpus NN, Schwartz GJ, Rosenblum MA, Rooney JF, Hendrix CW.   +14 more
europepmc   +1 more source